Algorae Pharmaceuticals Limited has released a press release.
LCT Signs Service Agreement with NZeno
Filed with ASX ·
6ix hasn’t read this filing yet.
Algorae Pharmaceuticals Limited on 6ix
Story so far
Earlier from Algorae Pharmaceuticals
- Results of Rights Issue
- Extension of Rights Issue
- Prospectus- Rights Issue
- LCT- Rights Issue
- LCT Receives New Zealand R&D Tax Credit
Later from Algorae Pharmaceuticals
- Half Yearly Report and Accounts
- LCT Completes Strategic A$1.285M Placement
- Preliminary Final Report and 2022 Financial Statements
- New milestone for LCTs AI development
- Quarterly Activity Report and Appendix 4C
Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.
Follow Algorae Pharmaceuticals